Bleehen NM - Search Results

1

Nicotinamide and pentoxifylline increase human leucocyte filterability: a possible mechanism for reduction of acute hypoxia.

Honess DJ, Kitamoto Y, Rampling MR, Bleehen NM. Honess DJ, et al. Among authors: bleehen nm. Br J Cancer Suppl. 1996 Jul;27:S236-40. Br J Cancer Suppl. 1996. PMID: 8763888 Free PMC article.

2

O6-methylguanine-DNA methyltransferase in pretreatment tumour biopsies as a predictor of response to temozolomide in melanoma.

Middleton MR, Lunn JM, Morris C, Rustin G, Wedge SR, Brampton MH, Lind MJ, Lee SM, Newell DR, Bleehen NM, Newlands ES, Calvert AH, Margison GP, Thatcher N. Middleton MR, et al. Among authors: bleehen nm. Br J Cancer. 1998 Nov;78(9):1199-202. doi: 10.1038/bjc.1998.654. Br J Cancer. 1998. PMID: 9820180 Free PMC article. Clinical Trial.

3

A Cancer Research Campaign (CRC) phase II trial of CB10-277 given by 24 hour infusion for malignant melanoma.

Bleehen NM, Calvert AH, Lee SM, Harper P, Kaye SB, Judson I, Brampton M. Bleehen NM, et al. Br J Cancer. 1994 Oct;70(4):775-7. doi: 10.1038/bjc.1994.395. Br J Cancer. 1994. PMID: 7917939 Free PMC article. Clinical Trial.

4

A phase II study of oral piritrexim in recurrent high-grade (III, IV) glioma.

Bleehen NM, Newman HV, Rampling RP, Ramsay JR, Roberts JT, Bedford P, Nethersell AB. Bleehen NM, et al. Br J Cancer. 1995 Sep;72(3):766-8. doi: 10.1038/bjc.1995.407. Br J Cancer. 1995. PMID: 7669591 Free PMC article. Clinical Trial.

5

Phase II trials of flavone acetic acid in advanced malignant melanoma and colorectal carcinoma.

Kerr DJ, Maughan T, Newlands E, Rustin G, Bleehen NM, Lewis C, Kaye SB. Kerr DJ, et al. Among authors: bleehen nm. Br J Cancer. 1989 Jul;60(1):104-6. doi: 10.1038/bjc.1989.230. Br J Cancer. 1989. PMID: 2803908 Free PMC article.

6

Insulin-like growth factor (IGF) and IGF binding proteins in growth hormone dysregulation and abnormal glucose tolerance in small cell lung cancer patients.

Reeve JG, Morgan J, Clark PM, Bleehen NM. Reeve JG, et al. Among authors: bleehen nm. Eur J Cancer. 1995;31A(9):1455-60. doi: 10.1016/0959-8049(95)00270-s. Eur J Cancer. 1995. PMID: 7577071

7

A phase I study of intravenous RMP-7 with carboplatin in patients with progression of malignant glioma.

Ford J, Osborn C, Barton T, Bleehen NM. Ford J, et al. Among authors: bleehen nm. Eur J Cancer. 1998 Oct;34(11):1807-11. doi: 10.1016/s0959-8049(98)00155-5. Eur J Cancer. 1998. PMID: 9893673 Clinical Trial.

8

BW12C perturbs normal and tumour tissue oxygenation and blood flow in man.

Falk SJ, Ramsay JR, Ward R, Miles K, Dixon AK, Bleehen NM. Falk SJ, et al. Among authors: bleehen nm. Radiother Oncol. 1994 Sep;32(3):210-7. doi: 10.1016/0167-8140(94)90020-5. Radiother Oncol. 1994. PMID: 7816940 Clinical Trial.

9

The combination of multiple doses of etanidazole and pimonidazole in 48 patients: a toxicity and pharmacokinetic study.

Bleehen NM, Maughan TS, Workman P, Newman HF, Stenning S, Ward R. Bleehen NM, et al. Radiother Oncol. 1991;20 Suppl 1:137-42. doi: 10.1016/0167-8140(91)90201-q. Radiother Oncol. 1991. PMID: 1826962 Clinical Trial.

10

BW12C: effects on tumour hypoxia, tumour thermosensitivity and relative tumour and normal tissue perfusion in C3H mice.

Honess DJ, Hu DE, Bleehen NM. Honess DJ, et al. Among authors: bleehen nm. Br J Cancer. 1991 Oct;64(4):715-22. doi: 10.1038/bjc.1991.387. Br J Cancer. 1991. PMID: 1911220 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results